A pharmacokinetic-pharmacodynamic model for the MET tyrosine kinase inhibitor, savolitinib, to explore target inhibition requirements for anti-tumour activity
MET 酪氨酸激酶抑制剂沃利替尼的药代动力学-药效学模型,用于探索抗肿瘤活性的靶标抑制要求
期刊:British Journal of Pharmacology
影响因子:6.8
doi:10.1111/bph.15301
Rhys D O Jones, Mike Grondine, Alexandra Borodovsky, Maryann San Martin, Michelle DuPont, Celina D'Cruz, Alwin Schuller, Ryan Henry, Evan Barry, Lillian Castriotta, Rana Anjum, Klas Petersson, Tarjinder Sahota, Ghada F Ahmed